Gastric cancer (GC) represents~ 10% of the global cancer-related deaths, increasingly
affecting the younger population in active stages of life. The high mortality of GC is due to …

Gastric cancer (GC) remains a serious threat to many people, representing the second
leading cause of cancer-related death worldwide. The lack of early diagnostic biomarkers …

Gastric cancer (GC) is currently the fourth most common malignancy and the third leading
cause of cancer-related deaths worldwide. Long non-coding RNAs (lncRNAs) …

Gastric cancer (GC) is one of the major public health concerns. Long non-coding RNAs
(lncRNAs) have been increasingly demonstrated to possess a strong correlation with GC …

Gastric cancer (GC) is one of the most prevalent malignant tumor types and the third leading
cause of cancer-related death worldwide. Its morbidity and mortality are very high due to a …

Gastric cancer (GC) is one of the most common cancers globally. Because of the high
frequency of tumor recurrence, or metastasis, after surgical resection, the prognosis of …

Background: Accumulating evidence has highlighted the crucial role of long noncoding
RNAs (lncRNAs) in the tumorigenesis of gastric cancer (GC), which is the most common …

Gastric cancer is one of the most common cancers and is the second leading cause of
cancer mortality worldwide. Therefore, it is urgent to explore new molecular biomarkers for …

Long noncoding RNAs (lncRNAs) recently have been recognized as having a critical role in
cancer development and progression. Gastric cancer remains a major clinical challenge …

Recent studies of the human transcriptome, most prominently by the ENCyclopedia Of DNA
Elements project, have revealed an unexpected number of noncoding RNAs (ncRNAs) …